Pump leak monitor for negative pressure wound therapy

Information

  • Patent Grant
  • 8444613
  • Patent Number
    8,444,613
  • Date Filed
    Wednesday, December 2, 2009
    14 years ago
  • Date Issued
    Tuesday, May 21, 2013
    11 years ago
  • Inventors
  • Original Assignees
    • (Gaithersburg, MD, US)
  • Examiners
    • Zalukaeva; Tatyana
    • Treyger; Ilya
    Agents
    • Graham; R. William
Abstract
A therapeutic device includes a fluid mover for one of raising, compressing, or transferring fluid, a therapeutic member operably connected to the fluid mover and actuated thereby, the therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of the fluid mover, a controller operably associated with the fluid mover for controlling operation thereof, and a leak, blockage, temperature, voltage or current sensor operably connected to the fluid mover and the controller and to sense a leak, blockage, temperature, voltage or current in the device and send a signal to the controller whereby the controller controls the fluid mover as a function of the sensed signal.
Description
BACKGROUND

1. Field of Invention


The invention is generally directed to a therapeutic device for the promotion of wound healing. More particularly, the present invention relates to providing fluid irrigation and vacuum drainage of a wound.


2. Related Art


These devices are normally used in clinical settings such as hospitals or extended care facilities, but patients can often be located in non-clinical environments, where portability, ease of use, and control of therapy parameters is necessary. Such places can, for example, include the home, office or motor vehicles, and at the extreme, military battlefields and other locations where electrical power may be unreliable or unavailable.


Negative pressure wound therapy (NPWT), also known as vacuum drainage or closed-suction drainage, is known. A vacuum source is connected to a semi-occluded or occluded therapeutic member, such as a compressible wound dressing. Various porous dressings comprising gauze, felts, foams, beads and/or fibers can be used in conjunction with an occlusive semi-permeable cover and a controlled vacuum source. In addition to negative pressure, there exist pump devices configured to supply positive pressure to another therapeutic member, such as an inflatable cuff for various medical therapies.


In addition to using negative pressure wound therapy, many devices employ concomitant wound irrigation. For example, a known wound healing apparatus includes a porous dressing made of polyurethane foam placed adjacent a wound and covered by a semi-permeable and flexible plastic sheet. The dressing further includes fluid supply and fluid drainage connections in communication with the cavity formed by the cover, foam and skin. The fluid supply is connected to a fluid source that can include an aqueous topical anesthetic or antibiotic solution, isotonic saline, or other medicaments for use in providing therapy to the wound. The fluid drainage can be connected to a vacuum source where fluid can be removed from the cavity and subatmospheric pressures can be maintained inside the cavity. The wound irrigation apparatus, although able to provide efficacious therapy, is somewhat cumbersome, difficult to use without trained professional medical personnel, and generally impractical outside the clinical setting. Such a device does not address various factors concerning patients outside clinical settings.


Some devices use vacuum sealing of wound dressings consisting of polyvinyl alcohol foam cut to size and stapled to the margins of the wound. Such dressings are covered by a semi-permeable membrane while suction and fluid connections are provided by small plastic tubes which are introduced into the foam generally through the patient's skin. Such devices alternate in time between vacuum drainage and the introduction of aqueous medicaments to the wound site, but do not do both simultaneously. While the prior devices have proven to be useful in fixed therapeutic sites, such devices require improvement to render broader and friendlier use.


SUMMARY OF THE INVENTION

It is an object to improve wound healing.


It is another object to improve devices for use in treating wounds.


It is an object to improve a pump for use in treating wounds.


It is yet another object to provide a therapeutic device for treating wounds which has improved portability.


It is yet another object to provide a therapeutic device for treating wounds which has improved ease of use.


It is yet another object to provide a therapeutic device for treating wounds which is equipped for predetermined and/or remote control of therapy parameters of time and pressure.


Thus, another object is to provide an improved therapeutic device which is equipped to deliver negative or positive pressure to a wound site.


One embodiment of the invention is directed to a disposable therapeutic device, which includes fluid moving means for one of raising, compressing, or transferring fluid, a therapeutic member operably connected to the fluid moving means and actuated thereby, the therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as a function of actuation of the fluid moving means; and control means operably associated with the fluid moving means for controlling operation thereof in a manner to restrict use of the fluid moving means by the patient in accordance with a predetermined treatment plan or duration and render the pump inoperable. A chargeable power source to supply power to the fluid moving means and the control means is provided.


More particularly, a wound irrigation system can use a fluid moving means, such as a diaphragm or piston-type pump, to raise, compress and transfer fluid in an electromechanical vacuum apparatus that includes a control means, such as a microprocessor-based device, having stored thereon software configured to control the electromechanical vacuum apparatus, and including one of a timer, means for remote control of the system, and means to restrict the operation of the apparatus to a predetermined treatment plan or duration.


A first vacuum pump can be electrically associated with the microcontroller and capable of generating a vacuum. An optional second vacuum pump is electrically associated with the microcontroller and is capable of maintaining a predetermined vacuum level. A first electronic vacuum-pressure sensor can be operably associated with the vacuum pump(s) and the microcontroller for monitoring vacuum level.


A fluid-tight wound exudate collection canister can be provided and can include an integrated barrier, such as a float valve, porous polymer filter or hydrophobic filter, to prevent contents from escaping the canister. Single-lumen tubing can be associated with the canister and vacuum pump(s) for communicating vacuum pressure therefrom. A second electronic vacuum-pressure sensor can be operably associated with the canister and the microcontroller for monitoring canister vacuum.


A dressing includes a porous material and semi-permeable flexible cover. Single-lumen tubing is associated with the dressing and the canister to communicate vacuum pressure therefrom. An irrigation vessel can be provided to contain a fluid to be used in irrigating the wound. Single-lumen tubing is associated with the irrigation vessel and the dressing to communicate fluid thereto.


The electromechanical vacuum apparatus housing may incorporate a compartment that can hold the irrigation vessel. The electromechanical vacuum apparatus can preferably include a device for regulating the quantity of fluid flowing from said irrigation vessel to said dressing. This device can comprise a mechanical or pneumatically actuated valve or clamp.


The electromechanical vacuum apparatus may include commercially available disposable storage batteries enabling portable operation thereof. Alternative power sources include rechargeable or reprocessable batteries which are removably connected to a housing, which contains the fluid moving means and control means, both of which require power in a waterproof environment. Other alternative power sources are solar energy, a manually operated generator in combination with a storage device such as a supercapacitor, or a pneumatic accumulator.


An embodiment of the invention includes a method for improving the generation and control of a therapeutic vacuum. In this embodiment, a multi-modal algorithm monitors pressure signals from a first electronic vacuum-pressure sensor associated with a vacuum pump and capable of measuring the output pressure from the pump. The algorithm further monitors pressure signals from a second electronic vacuum-pressure sensor associated with a collection canister and capable of measuring the subatmospheric pressure inside the canister. The second electronic vacuum-pressure sensor may also be associated with the wound dressing and capable of measuring the subatmospheric pressure inside the dressing. The canister is connected to the vacuum pump by a single-lumen tube that communicates subatmospheric pressure therefrom. The canister is connected to a suitable dressing by a single-lumen tube that communicates subatmospheric pressure thereto.


At the start of therapy, both the first and second electronic vacuum-pressure sensors indicate the system is equilibrated at atmospheric pressure. A first-mode control algorithm is employed to rapidly remove the air in the canister and dressing, and thus create a vacuum. The first-mode implemented by the control algorithm is subsequently referred to herein as the “draw down” mode. Once the subatmospheric pressure in the canister and dressing have reached a preset threshold as indicated by the first and second electronic vacuum-pressure sensors respectively, the algorithm employs a second-mode that maintains the desired level of subatmospheric pressure in both the canister and the dressing for the duration of the therapy. The second-mode implemented by the control algorithm is subsequently referred to herein as the “maintenance” mode.


The second-mode control algorithm is configured to operate the vacuum pump at a reduced speed thus minimizing unwanted mechanical noise. In an alternative embodiment, a second vacuum pump can be used for the maintenance mode, which has a reduced capacity, is smaller, and produces significantly lower levels of unwanted mechanical noise. The second-mode control algorithm is configured to permit the maintenance of vacuum in the presence of small leaks, which invariably occur at the various system interfaces and connection points. The method can be performed by, for example, a microprocessor-based device.


The control means can be provided with a timer for restricting the use as a function of a predetermined time. Alternatively, an identification member can be provided with the device such that the control means restricts use as a function of the identification member. The control means may include a Radio Frequency Identification Chip (RFID) chip available under the trademark Omni-ID™. The control means can be operably associated with a remote control for restricting the use of the device.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustrating the device of the invention.



FIG. 1A depicts a part of the invention.



FIG. 2 is a blockage alarm detection schematic.



FIG. 3 is a unit flow chart schematic.



FIG. 4 depicts a circuit diagram of a part of the invention.





DETAILED DESCRIPTION

As illustrated in FIG. 1, a disposable therapeutic device of the instant invention is generally designated by the numeral 10. The disposable therapeutic device 10 can preferably include a housing 12 which provides an improved therapeutic device with multiple uses and portability. The housing 12 can preferably be formed in a waterproof manner to protect components therein. In this regard, housing 12 can have a watertight sealed access panel 13 through which components can be accessed.


The device 10 can include a processor, which can be a microcontroller 14 having an embedded microprocessor, Random Access Memory (RAM) and Flash Memory (FM). FM can preferably contain the programming instructions for a control algorithm. FM can preferably be non-volatile and retains its programming when the power is terminated. RAM can be utilized by the control algorithm for storing variables such as pressure measurements, alarm counts and the like, which the control algorithm uses while generating and maintaining the vacuum.


An exemplary circuit diagram is provided in FIG. 4. The circuit 100 includes a power in source 102 which is operably connected to a power switch 104 to supply power to the circuit 100 via microcontroller 14. Light emitting diode(s) LED circuitry 105 can be operably connected to microcontroller 14.


A pressure sensor circuitry 108 is operably connected to microcontroller 14; Temperature sensor circuitry 110 is operably connected to microcontroller 14; and, Mute button switch 112 operably connects to microcontroller 14.


Buzzer circuitry 114 is operably connected to microcontroller 14. A motor current sensing resistor 116 and capacitor 118 operably connect to vacuum pump circuit connection 120 and metal-oxide-semiconductor field-effect transistor (MOSFET) 122 for amplifying/switching electronic signals and microcontroller 14 provides Pulse-width modulation (PWM) signal 124. Also, a pressure setting circuit 126 is operably connected to the microcontroller 14 for selecting operational vacuum level.


A membrane keypad and a LED or liquid crystal display (LCD) 16 can be electrically associated with processor 14 through a communication link, such as a cable. Keypad switches provide power control and are used to preset the desired pressure/vacuum levels. Light emitting diodes 17, 19 can be provided to indicate alarm conditions associated with canister fluid level, leaks of pressure in the dressing and canister, and power remaining in the power source.


Microcontroller 14 is electrically associated with, and controls the operation of, a first vacuum pump 18 and an optional second vacuum pump 20 through electrical connections. First vacuum pump 18 and optional second vacuum pump 20 can be one of many types including, for example, the pumps sold under the trademarks Hargraves® and Thomas®. Vacuum pumps 18 and 20 can use, for example, a reciprocating diaphragm or piston to create vacuum and can be typically powered by a direct current (DC) motor 18A that can also optionally use a brushless commutator for increased reliability and longevity. Motor current is used as an indication that motor 18A is running and active. Vacuum pumps 18 and 20 can be pneumatically associated with a disposable exudate collection canister 22 through a single-lumen tube 24.


In one embodiment, canister 22 has a volume which does not exceed 1000 ml. This can prevent accidental exsanguination of a patient in the event hemostasis has not yet been achieved at the wound site. Canister 22 can be of a custom design or one available off-the-shelf and sold under the trademark DeRoyal®.


In addition, a fluid barrier 26, which can be a back flow valve or filter, is associated with canister 22 and is configured to prevent fluids collected in canister 22 from escaping into tubing 24 and fouling the vacuum return path. Barrier 26 can be of a mechanical float design or may have one or more membranes of hydrophobic material such as those available under the trademark GoreTex™. Barrier 26 can also be fabricated from a porous polymer such as that which is available under the trademark MicroPore™ A secondary barrier 28 using a hydrophobic membrane or valve is inserted in-line with pneumatic tubing 24 to prevent fluid ingress into the system in the event barrier 26 fails to operate as intended. Pneumatic tubing 24 can connect to first vacuum pump 18 and optional second vacuum pump 20 through “T” connectors.


An identification member 30, such as radio frequency identification (RFID) tag, can be physically associated with the canister 22 and an RFID sensor 32 operably associated with the microcontroller 14 such that the microcontroller 14 can restrict use of the device 10 to a predetermined canister 22. Thus, if a canister 22 does not have a predetermined RFID chip, the device 10 will not operate. Another embodiment envisions software resident on microcontroller 14 which restricts the use of the device 10 to a predetermined time period such as 90 days for example. In this way, the patient using the device 10 may use the device 10 for a prescribed time period and then the device 10 automatically times out per a particular therapeutic plan for that patient. This also enables a reminder of the time and date for the next dressing change or physician appointment. It is also contemplated that the microcontroller 14 be operably provided with a remote control 15 and communication link, such as a transceiver, wherein the device 10 can be shut down remotely when a particular therapeutic plan for that patient has ended. Likewise, remote control 15 can be utilized to provide additional time after the therapeutic device times out.


Vacuum-pressure sensor 34 is pneumatically associated with first vacuum pump 18 and optional vacuum pump 20 and electrically associated with microcontroller 14. Pressure sensor 34 provides a vacuum-pressure signal to the microprocessor enabling a control algorithm to monitor vacuum pressure at the outlet of the vacuum pumps 18 and 20. The pressure sensor 34 reads pressure between vacuum pump 20 and canister 22.


An acoustic muffler can be provided and pneumatically associated with the exhaust ports of vacuum pumps 18 and 20 and configured to reduce exhaust noise produced by the pumps during operation. In normal operation of device 10, first vacuum pump 18 can be used to generate the initial or “draw-down” vacuum while optional second vacuum pump 20 can be used to maintain a desired vacuum within the system compensating for any leaks or pressure fluctuations. Vacuum pump 20 can be smaller and quieter than vacuum pump 18 providing a means to maintain desired pressure without disturbing the patient. It is contemplated by the instant invention that pumps 18 and 20 can also be employed to create a positive pressure for purposes of applying pressure to an inflatable member 35, such as a cuff or pressure bandage, through tubing 36. A switch 37 can be operatively disposed on housing 12 in operable connection with microcontroller 14 to enable selection of positive and negative pressure from pumps 18/20.


With respect to the pressure application, a proportional-integral-derivative controller (PID) loop is used to control the pressure. The PID controller attempts to correct error between a measured process variable and a desired set point by calculating and then outputting a corrective action that can adjust the process accordingly and rapidly, to keep the error minimal. As indicated in FIG. 3, the device 10 uses a main loop which runs continuously after initiation (set timers, port's input/output properties etc.) and readout of saved parameters (pressure setting, continuous or intermittent etc.). Motor 18A is controlled by the PID feedback control process with low-end-cut-off (to prevent motor stalling).


The DC motor 18A of the vacuum pump 18 is driven by a PWM method which is very efficient for providing intermediate amounts of electrical power between fully on and fully off. Pump motor 18A is controlled by PWM signal, PWM controls use pulse width modulation to regulate the current sent to the motor 18A. Unlike SCR controls which switch at line frequency, PWM controls produce smoother current at higher switching frequencies, typically between 1 and 20 kHz. At 20 kHz, the switching frequency is inaudible to humans, thereby eliminating a humming noise which switching at lower frequency produces. Some motor controllers for radio controlled models make use of the motor 18A to produce audible sound, most commonly simple beeps. Slider switch 37 (which is connected to pressure setting circuitry 126) is operatively provided to set the pressure out of the three possible settings of pressure. The exact pressure value for each level is decided by a calibration process. PWM controller can include a large reservoir capacitor and an H-bridge arrangement of switching elements (thyristors, Mosfets or transistors). To achieve such quiet operation, a starting current for the pump motor 18A is very low which uses very low power to run at low speed and can do so without causing a stall condition. Thus, the motor 18A running at such low speed that it makes little noise.


One or more battery (ies) 38 can preferably be provided to permit portable operation of the device 10. Battery 38 can be Lithium Ion (LiIon), Nickel-Metal-Hydride (NiMH), Nickel-Cadmium, (NiCd) or their equivalent, and can be electrically associated with microcontroller 14 through electrical connections. Battery 38 can be of a rechargeable type which is preferably removably disposed in connection with the housing 12 and can be replaced with a secondary battery 38 when needed. A recharger 40 is provided to keep one battery 38 charged at all times. Additionally, it is contemplated that the device 10 can be equipped to be powered or charged by recharger 40 or by circuits related with microcontroller 14 if such source of power is available. When an external source of power is not available and the device 10 is to operate in a portable mode, battery 38 supplies power to the device 10. The battery 38 can be rechargeable or reprocessable and can preferably be removably stored in a waterproof manner within housing 12 which also likewise contains the pumps 18, 20 and microcontroller 14. To manage the battery-life and keep the power budget low to maximize performance and achieve high efficiency, all the high current consumption components draw power directly from battery 38. The PWM method is used to drive the pump motor 18A. An exemplary battery can include a 4.2V lithium ion rechargeable battery. A standard charger IC is used to control the charging process.


A second pressure sensor 42 is pneumatically associated with canister 22 through a sensor port 43. Pressure sensor 42 can be electrically associated with microcontroller 14 and provides a vacuum-pressure signal to microprocessor enabling control algorithm to monitor vacuum pressure inside canister 22 and dressing 11. A “T” connector can be connected to port 43, to pressure sensor 42 and a vacuum-pressure relief solenoid 46 configured to relieve pressure in the canister 22 and dressing 11 in the event of an alarm condition, or if power is turned off. Solenoid 46, can be, for example, one available under the trademark Parker Hannifin® or Pneutronics®; Solenoid 46 is electrically associated with, and controlled by, microprocessor of microcontroller 14. Solenoid 46 can be configured to vent vacuum pressure to atmosphere when an electrical coil associated therewith is de-energized as would be the case if the power is turned off. An orifice restrictor 48 may optionally be provided in-line with solenoid 46 and pneumatic tube 44 to regulate the rate at which vacuum is relieved to atmospheric pressure when solenoid 46 is de-energized. Orifice restrictor 48 is, for example, available under the trademark AirLogic®.


A wound dressing 11 can preferably include a sterile porous substrate 50, which can be a polyurethane foam, polyvinyl alcohol foam, gauze, felt or other suitable material, a semi-permeable adhesive cover 52 such as that sold under the trademark DeRoyal® or Avery Denison®, an inlet port 56 and a suction port 54. Substrate 50 is configured to distribute vacuum pressure evenly throughout the entire wound bed and has mechanical properties suitable for promoting the formation of granular tissue and approximating the wound margins.


In addition, when vacuum is applied to dressing 11, substrate 50 creates micro- and macro-strain at the cellular level of the wound stimulating the production of various growth factors and other cytokines, and promoting cell proliferation. Dressing 11 is fluidically associated with canister 22 through single-lumen tube 44. The vacuum pressure in a cavity formed by substrate 50 of dressing 11 is largely the same as the vacuum pressure inside canister 22 minus the weight of any standing fluid inside tubing 44.


A fluid vessel 60, which can be a standard IV bag, contains medicinal fluids such as aqueous topical antibiotics, analgesics, physiologic bleaches, or isotonic saline. Fluid vessel 60 is removably connected to dressing 11 though port 56 and single-lumen tube 62.


An optional flow control device 64 can be placed in-line with tubing 62 to permit accurate regulation of the fluid flow from vessel 60 to dressing 11. In normal operation, continuous wound site irrigation is provided as treatment fluids move from vessel 60 through dressing 11 and into collection canister 22. This continuous irrigation keeps the wound clean and helps to manage infection. In addition, effluent produced at the wound site and collected by substrate 50 will be removed to canister 22 when the system is under vacuum.


The device 10 is particularly well suited for providing therapeutic wound irrigation and vacuum drainage and provides for a self-contained plastic housing configured to be worn around the waist or carried in a pouch over the shoulder for patients who are ambulatory, and hung from the footboard or headboard of a bed for patients who are non-ambulatory. Membrane keypad and display 16 is provided to enable the adjustment of therapeutic parameters and to turn the unit on and off.


Depressing the power button on membrane switch 16 will turn the power to device 10 on/off. While it is contemplated that the membrane switch 16 be equipped with keys to adjust therapeutic pressure up and down, the microcontroller 14 can preferably be equipped to control the pressure in accordance with sensed pressure and condition to maintain pressure in an operable range between −70 mmHg and −150 mmHg with a working range of between 0 and −500 mmHg, for example. Although these pressure settings are provided by way of example, they are not intended to be limiting because other pressures can be utilized for wound-type specific applications. The membrane 16 can also be equipped with LED 17 to indicate a leak alarm and/or LED 19 indicates a full-canister alarm. When either alarm condition is detected, these LEDs will light in conjunction with an audible chime which is also included in the device 10.


There are provided several alarms for providing leak, full canister, low battery detection, for example. A leak alarm detects a condition where the device 10 cannot maintain set pressure for a predetermined period, e.g., two minutes.


Full canister/blockage alarm can use a pulse response method which uses pressure increase for a fixed motor running time as an indication of existence of compressible medium (draped foam for instance), i.e., if canister 22 is full, a check valve 27 ## inside the canister 22 will cut off air passage to the dressing 11; for a 0.5 second 50% motor pulse a pressure increase can reach over 100 mm Hg, whereas the same motor pulse can only increase pressure less than 20 mm Hg if dressing 11 is connected.


Referring to FIG. 2, there is provided a flow chart of an exemplary operation. The blockage alarm detection can have two stages. Stage 1 detects a slow running motor. To do this, the motor 18A is quantified into “1”—running and “−1” for not running. Then the data is fed through a low pass filter. The filter's output represents the motor's activity, for instance a zero output from the filter means that motor is running 50% of the time.


When the filter output is smaller than a preset value D1, the low activity counter (Counter) starts counting. When motor's low activity lasted longer than C1 then stage 2 starts.


Stage 2: the motor is run a very short time (i.e. 0.5 Second) and the microprocessor 14 compares the pressure difference before and after the motor is run. Start pulse response test, takes pressure reading as Ps, then runs the motor for short time, reads pressure Pt and determines if Pt>Ps+Pi? (where Pi is a fixed constant). A larger difference means that there is very little volume in the system, and most likely the tubing 44 is blocked or canister 22 is full.


An exemplary portion of program software operably residing on the device 10 is as follows:














Code for pressure control:


void regulator(int T_Curr){









static BYTE PO;



int scPWMcount = 0, temp;



if(blocktest > 0) return;



if(iTemperature>0)



temp = RamDefaults.Pressure[RamSetting.bPressure]+ (−RamDefaults.Tc +







iTemperature)/20;









else



temp = RamDefaults.Pressure[RamSetting.bPressure];









if(RamSetting.bINT == 0)









iCurrError = temp − T_Curr;









 else









{









if(intercounter < INT_OFF)









iCurrError = temp − T_Curr;









else









iCurrError = −200 − T_Curr;









}









if(iCurrError < 10 ∥ (intercounter > INT_OFF && RamSetting.bINT == 1))









bReachPressure = 1;









else









bReachPressure = 0;









/* Calculate Proportional Term */



iPropTerm = iCurrError * PropGain;



if(iPropTerm > PROP_REG_LIM)









iPropTerm = PROP_REG_LIM;



else{









if(iPropTerm < −PROP_REG_LIM)









iPropTerm = −PROP_REG_LIM;









}









/* Calculate Integral Term */



iAccuError += iCurrError;



if(iAccuError > INTL_REG_LIM) iAccuError = INTL_REG_LIM;



if(iAccuError < −INTL_REG_LIM) iAccuError = −INTL_REG_LIM;



iIntlTerm = iAccuError * IntlGain;



if(iIntlTerm > INTL_REG_LIM)









iIntlTerm = INTL_REG_LIM;



else{









if(iIntlTerm < −INTL_REG_LIM)









iIntlTerm = −INTL_REG_LIM;









}









/* Sum Up Control Terms */









scPWMcount = (iPropTerm + iDeriTerm + iIntlTerm/20)/SCALE_FACTOR + 90;



if(scPWMcount > PWM_RESOLUTION)









scPWMcount = PWM_RESOLUTION;









else









{









if(PO > 0)



{









if(scPWMcount < bminDrive − 5)



{









scPWMcount = 0;



PO = 0;









}









}else



{









if(scPWMcount < bminDrive)



scPWMcount = 0;



else



PO = 1;









}









}









PWM8_1_WritePulseWidth(scPWMcount);







Code for blockage detection:









if(iPumpDuty < −140) // if pump runs really slow



{









if(blockcounter < BLOCK_TIME)









blockcounter++;









}



else









blockcounter = 0;









if(blockcounter == BLOCK_TIME)



{









if(blocktest == 0)



{









blocktest = 1;









}









}



if(blocktest>0)



{









if(blocktest == 1)



{









blockPressure = iPressure;









}



PWM8_1_WritePulseWidth(BLOCK_TEST_DUTY);



blocktest++;



if(blocktest >= BLOCK_TEST_CYCLE)



{









blocktest = 0;



PWM8_1_WritePulseWidth(0);



blockPressure = iPressure − blockPressure;



if(blockPressure > BLOCK_TEST_THRESHOLD)









blockcounter = BLOCK_TIME + 20; // indicates alarm









else









blockcounter = 0;









}









}










Housing 12 can incorporate a compartment configured in such a way as to receive and store a standard IV bag 60 or can be externally coupled to thereto. IV bag 60 may contain an aqueous topical wound treatment fluid that is utilized by the device 60 to provide continuous irrigation. A belt clip can provided for attaching to a patient's belt and an optional waist strap or shoulder strap is provided for patients who do not or cannot wear belts.


Canister 22 is provided for exudate collection and can preferably be configured as currently known in the field with a vacuum-sealing means and associated fluid barrier 26, vacuum sensor port 43 and associated protective hydrophobic filter, contact-clear translucent body, clear graduated measurement window, locking means and tubing connection means. Collection canister 22 typically has a volume less than 1000 ml to prevent accidental exsanguination of a patient if hemostasis is not achieved in the wound. Fluid barriers 26 can be, for example, those sold under the trademark MicroPore® or GoreTex® and ensure the contents of canister 22 do not inadvertently ingress into pumps 18, 20 of housing 12 and subsequently cause contamination of thereof.


Pressure sensor 42 enables microcontroller 14 to measure the pressure within the canister 22 as a proxy for the therapeutic vacuum pressure under the dressing 11. Optionally, tubing 62 can be multilumen tubing providing one conduit for the irrigation fluid to travel to dressing 11 and another conduit for the vacuum drainage. Thus, IV bag 60, tubing 62, dressing 11 and canister 22 provide a closed fluid pathway. In this embodiment, canister 22 would be single-use disposable and may be filled with a solidifying agent 23 to enable the contents to solidify prior to disposal. Solidifying agents are available, for example, under the trademark DeRoyal® and Isolyzer®. The solidifying agents prevent fluid from sloshing around inside the canister particularly when the patient is mobile, such as would be the case if the patient were travelling in a motor vehicle. In addition, solidifying agents are available with antimicrobials that can destroy pathogens and help prevent aerosolization of bacteria.


At the termination of optional multilumen tubing 62, there can be provided a self-adhesive dressing connector 57 for attaching the tubing to drape 52 with substantially air-tight seal. Dressing connector 11 can have an annular pressure-sensitive adhesive ring with a release liner that is removed prior to application. Port 56 can be formed as a port cut in drape 52 and dressing connector 57 would be positioned in alignment with said port. This enables irrigation fluid to both enter and leave the dressing through a single port. In an alternative embodiment, tube 62 can bifurcate at the terminus and connect to two dressing connectors 57 which allow the irrigation port to be physically separated from the vacuum drainage port thus forcing irrigation fluid to flow though the entire length of the dressing if it is so desired. Similarly, port 54 and connector 55 can be provided to connect optional multilumen tubing 44 to dressing 11. In this arrangement, the second lumen may be used to directly measure the pressure in dressing 11.


Fluid vessel 60 can be of the type which includes a self-sealing needle port situated on the superior aspect of the vessel 60 and a regulated drip port situated on the inferior aspect of the vessel. The needle port permits the introduction of a hypodermic needle for the administration of aqueous topical wound treatment fluids. These aqueous topical fluids can include a topical anesthetic such as Lidocaine, antibiotics such as Bacitracin or Sulfamide-Acetate; physiologic bleach such as Chlorpactin or Dakins solution; and antiseptics such as Lavasept or Octenisept. Regulated drip port permits fluid within vessel 60 to egress slowly and continuously into porous substrate 50 whereupon the therapeutic benefits can be imparted to the wound site. Single-lumen drainage tube 44 provides enough vacuum to keep the dressing 11 at sub-atmospheric pressure and to remove fluids, which include the irrigation fluid and wound exudates. With this modification, the need for an external fluid vessel and associated tubing and connectors can be eliminated making the dressing more user friendly for patient and clinician alike.


In typical clinical use of this alternate embodiment, dressing 11 is applied to the wound site by first cutting porous substrate 50 to fit the margins of the wound. Next, semi-permeable drape 52 is attached and sealed over the dressing and periwound. A hole approximately ⅜″ diameter can be made in drape 52 central to porous substrate 50. Fluid vessel 60 is attached by adhesive annular ring 57 with port 56 aligned with the hole previously cut in drape 52. Once the fluid vessel 60 is hermetically sealed to the drape 52, a properly prepared hypodermic needle is inserted in self-sealing needle port and fluid vessel 60 subsequently filled with the desired aqueous topical wound treatment solution.


For the majority of applications, the technique for providing therapeutic wound irrigation and vacuum drainage is illustrated. The single lumen drainage tube 44 is provided for the application of vacuum and removal of fluids from the wound site. Fluid vessel 60 can be situated outside and superior to semi-permeable substrate 50. An annular adhesive ring 57 is provided on port 56 for attachment of single-lumen irrigation tubing 62 to drape 52. Similarly, a needle port permits the introduction of a hypodermic needle for the administration of aqueous topical wound treatment fluids as described above, for example, a caregiver may want to add a topical antibiotic to a bag of isotonic saline. Adjustable optional flow control device 64 permits fluid within vessel 60 to egress slowly and continuously into porous substrate 50 through hole 56 in drape 52 whereupon the therapeutic benefits can be imparted to the wound site. Single-lumen drainage tube 44 provides enough vacuum to keep the dressing 11 at sub-atmospheric pressure and to remove fluids which include the irrigation fluid and wound exudates.


Because of the potential chemical interactions between the various materials used in the construction of dressing 11, attention must be paid to the types of aqueous topical wound fluids used to ensure compatibility. The above described embodiments are set forth by way of example and are not limiting. It will be readily apparent that obvious modifications, derivations and variations can be made to the embodiments. For example, the vacuum pumps described having either a diaphragm or piston-type could also be one of a syringe based system, bellows, or even an oscillating linear pump. Accordingly, the claims appended hereto should be read in their full scope including any such modifications, derivations and variations.

Claims
  • 1. A therapeutic device, which includes: a fluid mover for one of raising, compressing, or transferring fluid which includes a first draw-down pump for generating an initial draw down vacuum and a second pump in fluid communication with said first draw-down pump for maintaining a desired vacuum and for compensating for leaks and pressure fluctuations;a therapeutic member operably connected to said fluid mover and actuated thereby, said therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of said fluid mover;a controller operably associated with said fluid mover for controlling operation thereof, wherein said controller equipped to control pressure in accordance with sensed pressure at a vacuum and a canister for maintaining and applying a negative pressure compressible therapeutic dressing of a sterile porous substrate about a wound to form a seal about the wound through the negative pressure;a pressure sensor operably connected to said fluid mover and said controller and to sense a leak in said device and send a signal to said controller whereby said controller controls said fluid mover as a function of said sensed signal wherein said controller first obtains electronic data which quantifies that a pump motor is running by passing said data through a low pass filter and comparing output data against a preset value D1 to determine said pump motor is running, and upon said pump motor lasting a predetermined time C1, said controller initiates said first draw down pump obtains a pressure reading Ps after running said first draw down pump for less than about 1 second, said controller initiates a pulse test and obtains a start pressure Ps and causes said first draw-down pump to runs for a predetermined time and obtains a pressure Pt and determines if Pt>Ps+Pi, where Pi is a fixed constant indicating the a large difference and one of a full canister and line blockage;a check valve operatively connected to said controller interposed between said therapeutic member and said fluid mover to cut off fluid communication therebetween upon pressure reaching a predetermined threshold; andan RFID member physically associated with said canister and RFID sensor operably associated with said controller such that said controller restricts use of said canister as a function of said RFID member.
  • 2. A therapeutic device, which includes: a fluid mover for one of raising, compressing, or transferring fluid which includes a first draw-down pump for generating an initial draw down vacuum and a second pump in fluid communication with said first draw-down pump for maintaining a desired vacuum and for compensating for leaks and pressure fluctuations;a therapeutic member operably connected to said fluid mover and actuated thereby, said therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of said fluid mover;a controller operably associated with said fluid mover for controlling operation thereof, wherein said controller equipped to control pressure in accordance with sensed pressure at a vacuum and a canister for maintaining and applying a negative pressure compressible therapeutic dressing of a sterile porous substrate about a wound to form a seal about the wound through the negative pressure wherein said controller first obtains electronic data which quantifies that a pump motor is running by passing said data through a low pass filter and comparing output data against a preset value D1 to determine said pump motor is running, and upon said pump motor lasting a predetermined time C1, said controller initiates said first draw down pump obtains a pressure reading Ps after running said first draw down pump for less than about 1 second, said controller initiates a pulse test and obtains a start pressure Ps and causes said first draw-down pump to runs for a predetermined time and obtains a pressure Pt and determines if Pt>Ps+Pi, where Pi is a fixed constant indicating the a large difference and one of a full canister and line blockage;a pressure sensor operably connected to said fluid mover and said controller and to sense a fluid blockage in said device and send a signal to said controller whereby said controller controls said fluid mover as a function of said sensed signal;a check valve operatively connected to said controller interposed between said therapeutic member and said fluid mover to cut off fluid communication therebetween upon pressure reaching a predetermined threshold; anda disposable container removably operably interconnected to said fluid mover and to said therapeutic member to receive waste fluid therein as a result of actuation of said fluid mover and a solidifying agent disposed therein and a hydrophobic membrane operably disposed between said container and at least one of said pumps.
  • 3. A therapeutic device, which includes: a fluid mover for one of raising, compressing, or transferring fluid which includes a first draw-down pump for generating an initial draw down vacuum and a second pump in fluid communication with said first draw-down pump for maintaining a desired vacuum and for compensating for leaks and pressure fluctuations;a therapeutic member operably connected to said fluid mover and actuated thereby, said therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of said fluid mover;a controller operably associated with said fluid mover for controlling operation thereof, wherein said controller equipped to control pressure in accordance with sensed pressure at a vacuum and a canister for maintaining and applying a negative pressure compressible therapeutic dressing of a sterile porous substrate about a wound to form a seal about the wound through the negative pressure wherein said controller first obtains electronic data which quantifies that a pump motor is running by passing said data through a low pass filter and comparing output data against a preset value D1 to determine said pump motor is running, and upon said pump motor lasting a predetermined time C1, said controller initiates said first draw down pump obtains a pressure reading Ps after running said first draw down pump for less than about 1 second, said controller initiates a pulse test and obtains a start pressure Ps and causes said first draw-down pump to runs for a predetermined time and obtains a pressure Pt and determines if Pt>Ps+Pi, where Pi is a fixed constant indicating the a large difference and one of a full canister and line blockage;a temperature sensor operably connected to said controller and to sense a temperature in said device and send a signal to said controller whereby said controller controls said fluid mover as a function of said sensed signal;a check valve operatively connected to said controller interposed between said therapeutic member and said fluid mover to cut off fluid communication therebetween upon temperature reaching a predetermined threshold;an RFID member physically associated with said canister and RFID sensor operably associated with said controller such that said controller restricts use of said canister as a function of said RFID member; anda disposable container removably operably interconnected to said fluid mover and to said therapeutic member to receive waste fluid therein as a result of actuation of said fluid mover and a solidifying agent disposed therein and a hydrophobic membrane operably disposed between said container and at least one of said pumps.
  • 4. A therapeutic device, which includes: a fluid mover for one of raising, compressing, or transferring fluid;a therapeutic member operably connected to said fluid mover and actuated thereby, said therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of said fluid mover;a controller operably associated with said fluid mover for controlling operation thereof, wherein said controller equipped to control pressure in accordance with sensed pressure at a vacuum and a canister for maintaining and applying a negative pressure compressible therapeutic dressing of a sterile porous substrate about a wound to form a seal about the wound through the negative pressure wherein said controller first obtains electronic data which quantifies that a pump motor is running by passing said data through a low pass filter and comparing output data against a preset value D1 to determine said pump motor is running, and upon said pump motor lasting a predetermined time C1, said controller initiates said first draw down pump obtains a pressure reading Ps after running said first draw down pump for less than about 1 second, said controller initiates a pulse test and obtains a start pressure Ps and causes said first draw-down pump to runs for a predetermined time and obtains a pressure Pt and determines if Pt>Ps+Pi, where Pi is a fixed constant indicating the a large difference and one of a full canister and line blockage;a voltage sensor operably connected to said device and said controller and to sense a voltage in said device and send a signal to said controller whereby said controller controls said fluid mover as a function of said sensed signal;a check valve operatively connected to said controller interposed between said therapeutic member and said fluid mover to cut off fluid communication therebetween upon voltage reaching a predetermined threshold;an RFID member physically associated with said canister and RFID sensor operably associated with said controller such that said controller restricts use of said canister as a function of said RFID member; anda disposable container removably operably interconnected to said fluid mover and to said therapeutic member to receive waste fluid therein as a result of actuation of said fluid mover and a solidifying agent disposed therein and a hydrophobic membrane operably disposed between said container and at least one of said pumps.
  • 5. A therapeutic device, which includes: a fluid mover for one of raising, compressing, or transferring fluid which includes a first draw-down pump for generating an initial draw down vacuum and a second pump in fluid communication with said first draw-down pump for maintaining a desired vacuum and for compensating for leaks and pressure fluctuations;a therapeutic member operably connected to said fluid mover and actuated thereby, said therapeutic member operably disposably used on a patient in a manner to deliver therapy to the patient as function of actuation of said fluid mover;a controller operably associated with said fluid mover for controlling operation thereof wherein said controller equipped to control pressure in accordance with sensed pressure at a vacuum and a canister for maintaining and applying a negative pressure compressible therapeutic dressing of a sterile porous substrate about a wound to form a seal about the wound through the negative pressure wherein said controller first obtains electronic data which quantifies that a pump motor is running by passing said data through a low pass filter and comparing output data against a preset value D1 to determine said pump motor is running, and upon said pump motor lasting a predetermined time C1, said controller initiates said first draw down pump obtains a pressure reading Ps after running said first draw down pump for less than about 1 second, said controller initiates a pulse test and obtains a start pressure Ps and causes said first draw-down pump to runs for a predetermined time and obtains a pressure Pt and determines if Pt>Ps+Pi, where Pi is a fixed constant indicating the a large difference and one of a full canister and line blockage;a current sensor operably connected to said device and said controller and to sense current in said device and send a signal to said controller whereby said controller controls said fluid mover as a function of said sensed signal; anda check valve operatively connected to said controller interposed between said therapeutic member and said fluid mover to cut off fluid communication therebetween upon current reaching a predetermined threshold;an RFID member physically associated with said canister and RFID sensor operably associated with said controller such that said controller restricts use of said canister as a function of said RFID member; anda disposable container removably operably interconnected to said fluid mover and to said therapeutic member to receive waste fluid therein as a result of actuation of said fluid mover and a solidifying agent disposed therein and a hydrophobic membrane operably disposed between said container and at least one of said pumps.
  • 6. The disposable therapeutic device of claim 1, which includes a chargeable power source to supply power to said fluid mover.
  • 7. The disposable therapeutic device of claim 2, wherein said controller compares pressure of a first pressure reading obtained after a pulse of pressure with a second pressure reading taken after short run time of said device and if a pressure difference exceeds a predetermined amount, a signal is generated indicating one of a full canister and line blockage.
  • 8. The disposable therapeutic device of claim 7, wherein said short run time is less than about a second.
  • 9. The disposable therapeutic device of claim 1, wherein said controller compares pressure of a first pressure reading obtained after a pulse of pressure with a second pressure reading taken after short run time of said device and if a pressure difference exceeds a predetermined amount, a signal is generated indicating one of a full canister and line blockage.
  • 10. The disposable therapeutic device of claim 9, wherein said short run time is less than about a second.
  • 11. The disposable therapeutic device of claim 1, wherein said controller includes a timer for restricting said use as a function of a predetermined time.
  • 12. The disposable therapeutic device of claim 1, which further includes an identification member such that said controller restricts use as a function of a said identification member.
  • 13. The disposable therapeutic device of claim 1, wherein said controller enables for remotely control thereof for restricting said use.
  • 14. The disposable therapeutic device of claim 1, which further includes a disposable container removably operably interconnected to said fluid mover and to said therapeutic member to receive waste fluid therein as a result of actuation of said fluid mover.
  • 15. The disposable therapeutic device of claim 3, wherein said controller compares pressure of a first pressure reading obtained after a pulse of pressure with a second pressure reading taken after short run time of said device and if a pressure difference exceeds a predetermined amount, a signal is generated indicating one of a full canister and line blockage.
  • 16. The disposable therapeutic device of claim 15, wherein said short run time is less than about a second.
  • 17. The disposable therapeutic device of claim 4, wherein said controller compares pressure of a first pressure reading obtained after a pulse of pressure with a second pressure reading taken after short run time of said device and if a pressure difference exceeds a predetermined amount, a signal is generated indicating one of a full canister and line blockage.
  • 18. The disposable therapeutic device of claim 17, wherein said short run time is less than about a second.
  • 19. The disposable therapeutic device of claim 1, wherein said pressure sensor is operably connected to said controller and said therapeutic member such that said controller controls said fluid mover as a function of said sensed pressure.
  • 20. The disposable therapeutic device of claim 5, wherein said controller compares pressure of a first pressure reading obtained after a pulse of pressure with a second pressure reading taken after short run time of said device and if a pressure difference exceeds a predetermined amount, a signal is generated indicating one of a full canister and line blockage.
  • 21. The disposable therapeutic device of claim 20, wherein said short run time is less than about a second.
Parent Case Info

This is a continuation-in-part of U.S. Ser. No. 12/502,740 filed Jul. 14, 2009.

US Referenced Citations (163)
Number Name Date Kind
2232254 Morgan Feb 1941 A
2338339 LeMere et al. Jan 1944 A
2547758 Keeling Apr 1951 A
2969057 Simmons Jan 1961 A
3026526 Montrose Mar 1962 A
3026874 Stevens Mar 1962 A
3367332 Groves Feb 1968 A
3478736 Roberts et al. Nov 1969 A
3481326 Schamblin Dec 1969 A
3486504 Austin, Jr. Dec 1969 A
3610238 Rich, Jr. Oct 1971 A
3682180 McFarlane Aug 1972 A
3826254 Mellor Jul 1974 A
3874387 Barbieri Apr 1975 A
3896810 Akiyama Jul 1975 A
3908664 Loseff Sep 1975 A
3954105 Nordby et al. May 1976 A
3993080 Loseff Nov 1976 A
RE29319 Nordby et al. Jul 1977 E
4080970 Miller Mar 1978 A
4112947 Nehring Sep 1978 A
4149541 Gammons et al. Apr 1979 A
4169563 Leu Oct 1979 A
4172455 Beaussant Oct 1979 A
4224945 Cohen Sep 1980 A
4250882 Adair Feb 1981 A
4256109 Nichols Mar 1981 A
4261363 Russo Apr 1981 A
4275721 Olson Jun 1981 A
4297995 Golub Nov 1981 A
4373519 Errede et al. Feb 1983 A
4382441 Svedman May 1983 A
4392853 Muto Jul 1983 A
4419097 Rowland Dec 1983 A
4441357 Kahn et al. Apr 1984 A
4469092 Marshall et al. Sep 1984 A
4475909 Eisenberg Oct 1984 A
4480638 Schmid Nov 1984 A
4525166 Leclerc Jun 1985 A
4527064 Anderson Jul 1985 A
4540412 Van Overloop Sep 1985 A
4543100 Brodsky Sep 1985 A
4569674 Phillips et al. Feb 1986 A
4573965 Russo Mar 1986 A
4605399 Weston et al. Aug 1986 A
4608041 Nielsen Aug 1986 A
4624656 Clark et al. Nov 1986 A
4640688 Hauser Feb 1987 A
4661093 Beck et al. Apr 1987 A
4710165 McNeil et al. Dec 1987 A
4713052 Beck Dec 1987 A
4743232 Kruger May 1988 A
4755168 Romanelli et al. Jul 1988 A
4759354 Quarfoot Jul 1988 A
4764167 Tu Aug 1988 A
4765316 Marshall Aug 1988 A
4778456 Lokken Oct 1988 A
4820265 DeSatnick et al. Apr 1989 A
4820284 Hauri Apr 1989 A
4834110 Richard May 1989 A
4836192 Abbate Jun 1989 A
4838883 Matsuura Jun 1989 A
4840187 Brazier Jun 1989 A
4851545 Song et al. Jul 1989 A
4863449 Therriault et al. Sep 1989 A
4878901 Sachse Nov 1989 A
4906233 Moriuchi et al. Mar 1990 A
4917112 Kalt Apr 1990 A
4921492 Schultz et al. May 1990 A
4925447 Rosenblatt May 1990 A
4931519 Song et al. Jun 1990 A
4941882 Ward et al. Jul 1990 A
4953565 Tachibana et al. Sep 1990 A
4969880 Zamierowski Nov 1990 A
4969881 Viesturs Nov 1990 A
5035884 Song et al. Jul 1991 A
5086764 Gilman Feb 1992 A
5100396 Zamierowski Mar 1992 A
5106362 Gilman Apr 1992 A
5113871 Viljanto et al. May 1992 A
5149331 Ferdman et al. Sep 1992 A
5176663 Svedman Jan 1993 A
5228431 Giarretto Jul 1993 A
5261893 Zamierowski Nov 1993 A
5358494 Svedman Oct 1994 A
5527293 Zamierowski Jun 1996 A
5636643 Argenta et al. Jun 1997 A
5645081 Argenta et al. Jul 1997 A
5779657 Daneshvar Jul 1998 A
6071267 Zamierowski Jun 2000 A
6087549 Flick Jul 2000 A
6135116 Vogel Oct 2000 A
6142982 Hunt et al. Nov 2000 A
6196992 Keilman et al. Mar 2001 B1
6345623 Heaton et al. Feb 2002 B1
6398767 Fleischmann Jun 2002 B1
6432438 Shukla Aug 2002 B1
6458109 Henley et al. Oct 2002 B1
6551280 Knighton et al. Apr 2003 B1
6553998 Heaton et al. Apr 2003 B2
6685681 Lockwood et al. Feb 2004 B2
6695823 Lina et al. Feb 2004 B1
6695824 Howard et al. Feb 2004 B2
6752794 Lockwood et al. Jun 2004 B2
6755807 Risk et al. Jun 2004 B2
6770061 Wildman Aug 2004 B2
6800074 Henley et al. Oct 2004 B2
6814079 Heaton et al. Nov 2004 B2
6840960 Bubb Jan 2005 B2
6841715 Roberts Jan 2005 B2
6855135 Lockwood et al. Feb 2005 B2
6856821 Johnson Feb 2005 B2
6979324 Bybordi et al. Dec 2005 B2
7004915 Boynton et al. Feb 2006 B2
7022113 Lockwood et al. Apr 2006 B2
7070584 Johnson et al. Jul 2006 B2
7108683 Zamierowski Sep 2006 B2
7117869 Heaton et al. Oct 2006 B2
7128735 Weston Oct 2006 B2
7144390 Hannigan et al. Dec 2006 B1
7195624 Lockwood et al. Mar 2007 B2
7198046 Argenta et al. Apr 2007 B1
7214202 Vogel May 2007 B1
7216651 Argenta et al. May 2007 B2
7273054 Heaton et al. Sep 2007 B2
7276051 Henley et al. Oct 2007 B1
7279612 Heaton et al. Oct 2007 B1
7316672 Hunt et al. Jan 2008 B1
7338482 Lockwood et al. Mar 2008 B2
7361184 Joshi Apr 2008 B2
7381859 Hunt et al. Jun 2008 B2
7422576 Boynton et al. Sep 2008 B2
7438705 Karpowicz et al. Oct 2008 B2
7520872 Biggie et al. Apr 2009 B2
7524286 Johnson Apr 2009 B2
7524315 Blott et al. Apr 2009 B2
7532953 Vogel May 2009 B2
7534240 Johnson May 2009 B1
7534927 Lockwood et al. May 2009 B2
7540848 Hannigan et al. Jun 2009 B2
7553306 Hunt et al. Jun 2009 B1
7794438 Henley et al. Sep 2010 B2
8011039 Stryker et al. Sep 2011 B2
20010031943 Urie Oct 2001 A1
20020065494 Lockwood et al. May 2002 A1
20030225355 Butler Dec 2003 A1
20040002670 Mothersbaugh et al. Jan 2004 A1
20040219133 Lyles Nov 2004 A1
20050095723 DiTrolio et al. May 2005 A1
20050137539 Biggie et al. Jun 2005 A1
20050203469 Bobroff et al. Sep 2005 A1
20050209574 Boehringer et al. Sep 2005 A1
20050228329 Boehringer et al. Oct 2005 A1
20050245904 Estes et al. Nov 2005 A1
20060025727 Boehringer et al. Feb 2006 A1
20060100586 Karpowicz et al. May 2006 A1
20070027414 Hoffman et al. Feb 2007 A1
20070032762 Vogel Feb 2007 A1
20070032763 Vogel Feb 2007 A1
20070219532 Karpowicz et al. Sep 2007 A1
20070243512 King Oct 2007 A1
20100100075 Weston et al. Apr 2010 A1
20100298792 Weston et al. Nov 2010 A1
Foreign Referenced Citations (17)
Number Date Country
28 09-828 Sep 1978 DE
41 11 122 Apr 1993 DE
64055 Oct 1945 DK
0 880 953 Dec 1998 EP
641061 Aug 1950 GB
1273342 May 1972 GB
0587941 Jan 1978 SU
1268175 Nov 1986 SU
8001139 Jun 1980 WO
8905133 Jun 1989 WO
WO-9011795 Oct 1990 WO
9100718 Jan 1991 WO
WO-9116030 Oct 1991 WO
WO-9219313 Nov 1992 WO
WO-9220299 Nov 1992 WO
WO-9605873 Feb 1996 WO
WO0130422 May 2001 WO
Non-Patent Literature Citations (43)
Entry
Nicolov, An., “A Method of Treatment of Postphlebitic and Varicose Trophyc Ulcers of the Lower Extremities by Vacuum”, 6 pages, Translation from Bulgarian into English, 1979, Sugery, XXXIV, 1981, Apr. 4, 1979.
Borzov, M. V., et al., “The Vacuum Therapy of Some Skin Conditions”, The Odessa N.I. Pirogov Medical Institute, Submitted, Apr. 9, 1965.
Sames, C. Patrick, “Sealing of Wounds with Vacuum Drainage”. Date unknown, prior to Aug. 8, 2004.
Betancourt, M.D., Sergio, “A Method of Collecting the Effluent from Complicated Fistula of the Small Intestine”. Department of Surgery, Allegheny General Hospital, Pittsburgh, p. 375. Date unknown, prior to Aug. 8, 2004.
Ramirez, Oscar M. et al., “Optimal Wound Healing Under Op-Site Dressing”Ideas and Innovations, vol. 73, No. 3, pp. 474-475, 1983.
Byers, M.D., Robert M. et al., “Clinical Effects of Closed Suction Drainage on Wound Healing in Patients with Head and Neck Cancer”, Arch Otolaryngol, vol. 108, Nov. 1982, pp. 723-726.
P. Svedman et al, “Treatment of leg ulcers by intermittent irrigation through a felt dressing”, IRCS Med. Sci., 13, 489-490 (1985).
P. Svedman, “A Dressing Allowing Continuous Treatment of a Biosurface”IRCS Medical Science: Biomedical Technology; Clinical Medicine; Surgery and Transplantation, 7, 221 (1979).
Egnell Minor, Instruction book, First Edition, 300 7502 [Feb. 1975] (w/ partial English Translation).
Addition to the Users Manual Concerning Overflow Protection concerns all Egnell pumps, dated Feb. 3, 1983 (w/partial English translation).
Wolthuis et al., “Physiological Effects ofLocally applied Reduced Pressure in Man,” Physiological Reviews, 54: 566-595, Jul. 1974.
Lundvall et al., “Transmission of externally applied negative pressure of the underlying tissue. A study on the upper arm of man,” Acta Physiol Scand, 136: 403-409, accepted Jan. 28, 1989.
Dunlop et al., “Vacuum drainage of groin wounds after vascular surgery: a controlled trial,” Br. J. Surg., 77: 562-563 (1990).
Bucalo et al., “Inhibition of cell proliferation by chronic wound fluid,” Wound Repair and Regeneration, Miami, 1993, 181-186.
Urschel et al., “The effect of mechanical stress on soft and hard tissue repair; a review,” British Journal of Plastic Surgery, 41, 182-186, 1988.
Jeter, K.R. et al. (eds.), “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care: Health Management Publications, 1990, pp. 240-246.
Fleischmann, W., Wund Forum Spezial. IHW '94. “Vakuumversiegelung zur Behandlung von Problemwunden,” (English translation: Vacuum sealing for Treatment of Problematical Wounds.).
Fleischmann, W. et al., Acta Orthopaedica Belgica. vol. 58, Suppl. I-1992, “Treatment of Bone and Soft Tissue Defects in Infected Nonunion.”.
Fleischmann, W. et al., Unfall Chirurgie, Springer-Varlag 1993, “Vakuumverseigelung zur Behandlung des Weichteilschadens bei offenen Frakturen.”.
Valenta, A., American Journal of Nursing, Apr. 1994, “Using the Vacuum Dressing Alternative for Difficult Wounds.”.
Mulder, G.D. et al. (eds.), Clinicians' Pocket Guide to Chronic Wound Repair, (Spartanburg, SC: Wound Healing Publications), 1991, pp. 54-55.
Morykwas, M. et al., “Use of Negative Pressure to Increase the Rate of Granulation Tissue Formation in Chronic Open Wounds,” Extracellular Matrix and Healing, pp. 800, 1993.
Schneider, A. et al., “A New and Reliable Method of Securing Skin Grafts to the Difficult Recipient Bed,” Plastic and Reconstructive Surgery, vol. 102(4), Sep. 1998, pp. 1195-1198.
Morykwas, M. et al., “Nonsurgical Modalities to Enhance Healing and Care of Soft Tissue Wounds,” Journal of the Southern Orthopaedic Association, vol. 6, No. 4, Winter 1997, pp. 279-288.
Tittle, K. et al., “VariDyne—new standards in postoperative wound drainage,” Unfall Chirurgie, 1988, 14(2):104-107.
Genecov, A. et al., “A Controlled Subatmospheric Pressure Dressing Increases the Rate of Skin Graft Donor Site Reepithelialization,” Annals of Plastic Surgery, col. 40, No. 3, Mar. 1998, pp. 219-225.
Morykwas, M. et al., “Vacuum Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation”—Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997.
Argenta, L. et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Clinical Experience,” Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997.
Neumann, P. et al., “Gelatin-based sprayable foam as a skin substitute,” Journal of Biomedical Materials Research, 1981; vol. 15, pp. 9-18.
N. A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissue”, Current Problems in Modern Clinical Surgery, 1986; pp. 94-96.
N. A. Bagautdinov, et al., “Vacuum and Vacuum Sorption Treatment of Open Septic Wounds”, USSR Ministry of Health USSR Academy of Medical Sciences A.V. Vyshnevsky Institute of Surgery of the USSR AMS, 1986, pp. 91-92.
Chinn, Steven D et al., “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81.
Wooding-Scott, Margaret et al. , “No Wound is Too Big for Resourceful Nurses”, RN, Dec. 1988, pp. 22-25.
P. Svedman, M.D., “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133.
Arnljots, Bjorn, et al. “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J Plast Reconstr Surg 19: 211-213, 1985.
Teder, H. et al., “Continuous Wound Irrigation in the Pig”, Journal of Investigative Surgery, vol. 3, pp. 399-407, 1990.
Chariker M.D., Mark E., “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage”, Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63.
Mizuno M.D., Katsuyoshi, “Suctioning Sponge”, Arch Ophthalmol, vol. 101, Feb. 1983, p. 294.
Nicolov, An., “A Method of Treatment of Postphlebitic and Varicose Trophyc Ulcers of the Lower Extremities by Vacuum”, 6 pages, Translation from Bulgarian into English, 1979, Surgery, XXXIV, 1981, Apr. 4, 1979.
Smith, S.R.G., et al., “Surgical Drainage”, Surgical Symposium, British Journal of Hospital Medicine, Jun. 1985, pp. 308, 311, 314-315.
Westaby, S. et al., “Treatment of Purulent Wounds and Fistulae with an Adhesive Wound Irrigation Device”, Instruments and Techniques, Annals of the Royal College of Surgeons of England (1981), vol. 63, pp. 353-356.
Borzov, M.V., et al., “The Vacuum Therapy of Some Skin Conditions”, The Odessa N.I. Pirogov Medical Institute, Submitted, Apr. 9, 1965.
Svedman P., “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534.
Related Publications (1)
Number Date Country
20110015593 A1 Jan 2011 US
Continuation in Parts (1)
Number Date Country
Parent 12502740 Jul 2009 US
Child 12629100 US